top of page

Assessment & Decision Process for the Recognition of a Conformity Assessment Body -IMDRF

International Medical Device Regulators Forum (IMDRF) published a final document describing the “Assessment and Decision Process for the Recognition of a Conformity Assessment Body (CAB) Conducting Medical Device Regulatory Reviews”.

This is one document in a collection of documents produced by the IMDRF intended to improve the efficiency and effectiveness of the review process for the marketing of medical devices.


The purpose of this document is to explain the assessment process and outcomes, including the method to “grade and manage” nonconformities resulting from a recognizing Regulatory Authority’s assessment of a CAB; and to document the decision process for recognizing a CAB or cessation of recognition. To prevent confusion between marketing review activities performed by a CAB and the activities performed by medical device Regulatory Authority Assessors for CAB recognition and surveillance, in this document, the latter are designated as “assessments.


This document defines:

- the process and lifecycle for recognizing, maintaining, or ceasing recognition of a CAB;

- the process of managing, grading, and closure of assessment nonconformities issued to a CAB; and,

- the outcomes of an initial, surveillance, or re-recognition assessment of a CAB

Comments


I Sometimes Send Newsletters

Thanks for submitting!

  • LinkedIn
  • Facebook
  • Twitter
  • Instagram

DISCLAIMER

The views expressed in this publication do not necessarily reflect the views of any guidance of government, health authority, it's purely my understanding. This Blog/Web Site is made available by a regulatory professional, is for educational purposes only as well as to give you general information and a general understanding of the pharmaceutical regulations, and not to provide specific regulatory advice. By using this blog site you understand that there is no client relationship between you and the Blog/Web Site publisher. The Blog/Web Site should not be used as a substitute for competent pharma regulatory advice and you should discuss from an authenticated regulatory professional in your state.  We have made every reasonable effort to present accurate information on our website; however, we are not responsible for any of the results you experience while visiting our website and request to use official websites.

bottom of page